Rosuvastatin Completed Phase 3 Trials for Dyslipidemias / Hypertension,Essential Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT0065460248-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
NCT03026933Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled
NCT03156842Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia